We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has updated its guidance on conducting clinical trials during the COVID-19 pandemic with an extensive Q&A section, including a long list of factors to consider when deciding the status of ongoing trials and ones soon to be initiated. Read More
The drug is currently approved for treatment of patients with multicentric Castleman disease, a rare condition that affects the lymph nodes and related tissues. Read More